View |
|
DR-XY41477
|
Ambroxol Hydrochloride
|
Amucsol
|
15mg/5mL
|
Oral Solution
|
Mucolytic
|
Yangzhou No. 3, Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
06 September 2022
|
19 December 2027
|
View |
|
DR-XY41478
|
Cefepime (as hydrochloride)
|
Zepim
|
1 g
|
Powder for Injection
|
Antibacterial (Cephalosporin)
|
Kyongbo Pharmaceutical, Co., Ltd.
|
Korea
|
Automatic Renewal
|
17 October 2022
|
18 December 2027
|
View |
|
DR-XY41480
|
Ambroxol Hydrochloride
|
Amucsol
|
15mg/5mL
|
Oral Solution
|
Mucolytic
|
Yangzhou No. 3, Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
24 September 2022
|
19 December 2027
|
View |
|
DR-XY41485
|
Esomeprazole (As Sodium)
|
Esoflux
|
40mg
|
Lyophilized Powder For Injection
|
Proton Pump Inhibitor
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Automatic Renewal
|
20 September 2022
|
19 December 2027
|
View |
|
DR-XY41492
|
Tramadol Hydrochloride
|
Traman
|
50mg/ mL
|
Solution for Injection (IM/IV)
|
-
|
Kwality Pharmaceuticals Pvt. Ltd.
|
India
|
-
|
12 March 2021
|
19 December 2025
|
View |
|
DR-XY41496
|
Netilmicin (as Sulfate)
|
Netrozin
|
50mg/mL (100mg/2mL)
|
Solution for Injection (I.M./I.V.)
|
Antibacterial (Aminoglycoside)
|
Jiangsu Ruinian Qianjin Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
22 August 2022
|
19 December 2027
|
View |
|
DR-XY41497
|
Metformin Hydrochloride
|
Glyformet
|
500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic (Biguanide)
|
Lloyd Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
12 October 2022
|
18 December 2027
|
View |
|
DR-XY41499
|
Metformin Hydrochloride
|
None
|
850 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
10 October 2022
|
18 December 2027
|
View |
|
DR-XY41500
|
Beclomethasone Dipropionate
|
Clomate
|
100mcg
|
Powder For Inhalation
|
Corticosteroid (Glucocorticoid)
|
Jewin Pharmaceutical (shandong) co., ltd.
|
China
|
Automatic Renewal
|
08 July 2022
|
18 December 2027
|
View |
|
DR-XY41501
|
Beclomethasone Dipropionate
|
Clomate
|
200mcg
|
Powder For Inhalation
|
Corticosteroid (Glucocorticoid)
|
Jewin Pharmaceutical (shandong) co., ltd.
|
China
|
Automatic Renewal
|
05 July 2022
|
18 December 2027
|
View |
|
DR-XY41502
|
Escitalopram (as Oxalate)
|
Ecsapro
|
20mg
|
Film-Coated Tablet
|
Antidepressant
|
Jewin pharmaceutical (shandong) co., ltd.
|
China
|
Renewal
|
22 March 2023
|
17 April 2028
|
View |
|
DR-XY41503
|
Escitalopram (as Oxalate)
|
Ecsapro
|
10mg
|
Film-Coated Tablet
|
Antidepressant
|
Jewim Pharmaceutical (Shandong) Co., Ltd.
|
China
|
Renewal
|
22 March 2023
|
17 April 2028
|
View |
|
DR-XY41504
|
Escitalopram (as Oxalate)
|
Ecsapro
|
5mg
|
Film-Coated Tablet
|
Antidepressant
|
Jewin Pharmaceuticals (Shandong) Co., ltd.,
|
China
|
Renewal
|
22 March 2023
|
17 April 2028
|
View |
|
DR-XY41508
|
Ibuprofen
|
Dolex
|
100mg/5mL
|
Oral Suspension
|
Non-Steroidal Anti-Inflammatory Drug/NSAID (Propionic Acid Derivative)
|
Yangzhou No. 3, Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
22 March 2023
|
17 April 2028
|
View |
|
DR-XY41516
|
Lithium Carbonate
|
Microlit
|
400 mg
|
Sustained Release Tablet
|
Antipsychotic
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
20 September 2022
|
27 December 2027
|
View |
|
DR-XY41519
|
Metoclopramide Hydrochloride
|
Metofar
|
5 mg/mL (10 mg/2 mL)
|
Solution For Injection
|
Gastrokinetic (Prokinetic)
|
Scott Edil Pharmacia Ltd.
|
India
|
Automatic Renewal
|
20 January 2023
|
27 December 2027
|
View |
DR-XY41520_PI_01.pdf
|
DR-XY41520
|
Paclitaxel
|
Paclitex
|
100 mg/17 mL
|
Concentrate for Solution For I.V. Infusion
|
-
|
Laboratorio Kemex S.A.
|
Argentina
|
Automatic Renewal (Correction)
|
16 January 2024
|
27 December 2025
|
View |
|
DR-XY41521
|
Mometasone Furoate
|
Lomeane
|
1mg/g (0.1%)
|
cream
|
-
|
Shou Chan Industrial Co., Ltd.
|
Taiwan
|
-
|
18 June 2020
|
27 December 2024
|
View |
|
DR-XY41522
|
Sodium Ascorbate
|
Hex-Cee
|
568.18 mg
|
Capsule
|
Vitamin C
|
Flamingo Pharmaceuticals Ltd
|
India
|
Renewal
|
20 September 2022
|
27 December 2027
|
View |
|
DR-XY41526
|
Paclitaxel
|
Paclizel
|
100mg/16.7mL
|
Solution for Infusion (I.V.)
|
Antineoplastic Agent (Cell cyle-specific agent)
|
Haikou Pharmaceutical Factory Co., Ltd.
|
China
|
Automatic Renewal
|
07 September 2022
|
26 December 2027
|